@GoldenEaglev2
'It is also a perfect testing ground for new genetics in a production setting. Can't do that at Northern because it's a shit box from like four decades ago.'
What does this even mean?
'The other company I was looking at was IHL. They have 3 or more clinical trials at either phase 2 or phase 1, but they are collaborating with the FDA and their formulations are more complex than simple low-dose CBD'
You do realize we aren't even looking at using Satipharm in US markets at the moment and that the OTC scheme is for low-dose CBD products.
Ann: Share Purchase Plan, page-35
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $14.01M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.1¢ | $34.22K | 1.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 477821 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 244882 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| CAN (ASX) Chart |